Skip to content
Screener

Arrowhead Research ARWR Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

ALN
Alnylam PharmaceuticalsALNY
$45.93M-0.4%
Assembly Biosciences logo
Assembly BiosciencesASMB
$590K+11.5%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$631K+12.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$14.78M+11.9%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$5.03M-1.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$3.32M-30.7%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.38B+420%
Enterprise value$12.3B+421%
P/S19.9×+15.7×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Accounts payable30,747$17,674
Accrued expenses76,58590,419
Accrued payroll and benefits20,36626,895
Lease liabilities7,7747,289
Deferred revenue108,5432,399
Credit facility40,00040,000
Other liabilities11,20510,811
Total current liabilities295,220195,487

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's operating lease liabilities (current)?
Arrowhead Research (ARWR) reported operating lease liabilities (current) of $7.77M in Q1 2026.
How has Arrowhead Research's operating lease liabilities (current) changed year-over-year?
Arrowhead Research's operating lease liabilities (current) increased by 14.6% year-over-year, from $6.78M to $7.77M.
What is the long-term trend for Arrowhead Research's operating lease liabilities (current)?
Over 4 years (2021 to 2025), Arrowhead Research's operating lease liabilities (current) has grown at a 34.2% compound annual growth rate (CAGR), from $2.25M to $7.29M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Arrowhead Research's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude